Clinical trials
Women clinical trials
Below are recruiting women clinical trials, each written for real people, not researchers. We’re tracking 1,350 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04504188Recruiting
Adjusting beta-blocker dose for women using a wearable defibrillator
This trial checks whether doctors can use a lower or adjusted dose of beta-blocker medicine in women who are wearing a wearable defibrillator (WCD). It aims to find an approach that’s safe and works while you’re using the device for about 3 months to protect your heart.
Cincinnati, OhioAges 18 years+ - NCT04520048Recruiting
Blood vessel tests to predict preeclampsia worsening in pregnancy
This study measures blood vessel–related markers in pregnant people who already have high blood pressure or early preeclampsia. The goal is to predict who is more likely to get worse, so care can be better targeted.
Bobigny, Seine Saint DenisAges 18–40 - NCT04529889Recruiting
Study of gestational diabetes during pregnancy and child outcomes
This study follows pregnant people with gestational diabetes to see how it affects mothers and babies over time. The team may use this information to better understand risks and care for both you and your child.
Guangzhou, GuangdongAges Any age - NCT04545957Recruiting
Radiation planning study using MRI for adults with cancer
This trial tests a “master protocol” approach to use MRI (a detailed body scan) to help plan radiation treatment for people with cancer. It may help doctors customize radiation more accurately, depending on your specific cancer type.
Boston, MassachusettsAges 18 years+ - NCT04588402Recruiting
Tests whether HPV vaccination prevents cervical HPV infection in young women
This study looks at whether HPV vaccination lowers the chance of getting HPV in the cervix. It will collect cervical samples and ask questions to see how vaccination affects infection in women in Sikkim, India.
Gangtok, SikkimAges 18–22 - NCT04590560Recruiting
Best timing for breast screening in women ages 45–49 and 70–74
This study looks at the best time interval for breast cancer screening (mammograms) for women in two age groups. The goal is to reduce missed cancers while avoiding unnecessary tests.
Meldola (FC), FCAges 45–49 - NCT04634994RecruitingEarly Phase 1
Brain scans to measure synapses in multiple sclerosis
This early study uses special brain scans (PET and MRI) to measure “synapse density” (how many connection points brain cells have) in people with multiple sclerosis (MS). It may help researchers understand MS biology and improve future treatments.
Boston, MassachusettsAges 18–60 - NCT04650880Recruiting
Vitamin D study for irregular periods from PCOS
This trial studies whether taking vitamin D can improve ovulation (the release of an egg) in people with PCOS who have long, irregular menstrual cycles. It may help some participants have more regular ovulation and cycle timing, but you would be monitored with vaginal ultrasound and blood tests.
Hong KongAges 18–40 - NCT04675749Recruiting
Quality of life study in adult women with X-ALD
This study looks at quality of life in adult women who have X-linked adrenoleukodystrophy (X-ALD). It may help researchers understand how this condition affects daily life and well-being.
Leipzig, SaxonyAges 18 years+ - NCT04683679RecruitingPhase 2
Radiation plus pembrolizumab and olaparib for certain breast cancers
This study tests whether adding the drugs pembrolizumab and olaparib (or similar “radiosensitizers”) to radiation can improve outcomes for women with advanced breast cancer that is triple-negative or ER-positive/Her2-negative. It’s designed for cancers that have spread or come back and where radiation is being considered to control disease.
Basking Ridge, New JerseyAges 18 years+ - NCT04701645RecruitingPhase 1
Microdevice study for advanced ovarian or related cancers
This Phase 1 study tests a tiny implanted device placed in the abdomen to help evaluate or treat advanced ovarian, fallopian tube, or peritoneal cancer. If you qualify, you’d also have additional tests and surgery as part of your usual care plan.
Boston, MassachusettsAges 18 years+ - NCT04759443Recruiting
Skin testing to detect small-fiber nerve damage
This study looks for small-fiber neuropathy (nerve damage that can affect pain and sensation) by examining skin properties. It may help researchers find easier ways to detect this condition using skin-based testing.
Boston, MassachusettsAges 18 years+ - NCT04798469RecruitingPhase 2
Testosterone to reduce long-term spine pain in men on opioids
This Phase 2 study tests whether taking testosterone can lessen chronic non-cancer spinal pain in men who have low testosterone while using opioid pain medicines. It may help by improving hormone levels that could be affecting pain and overall wellbeing.
Boston, MassachusettsAges 18 years+ - NCT04811703RecruitingPhase 1
Testing aerosol chemotherapy through the belly for advanced ovarian cancer
This Phase 1 study tests a new way to deliver chemotherapy inside the abdomen (belly) using a pressurized aerosol during a procedure, along with standard blood (IV) chemotherapy. It may help people with advanced ovarian cancer whose tumors have not progressed but are not removable with surgery yet.
LilleAges 18–75 - NCT04817566Recruiting
Brain stimulation and training for thinking problems after breast cancer
This study tests whether brain stimulation plus cognitive training can improve thinking and memory problems in women after chemotherapy for breast cancer. It may help if you still feel “foggy” or have trouble concentrating months after treatment.
GreifswaldAges 18–65 - NCT04843111Recruiting
Registry study for pregnancy exposure to MenQuadfi vaccine
This is an observational registry that collects information about pregnant people and their babies when MenQuadfi® (a meningitis vaccine) was given during pregnancy or shortly before pregnancy. It helps researchers understand what happens to women and offspring after this vaccine exposure.
Swiftwater, PennsylvaniaAges Any age - NCT04846959Recruiting
Pregnancy outcomes study for people exposed to risankizumab
This study looks at pregnancy outcomes in people who took risankizumab during pregnancy (or shortly before getting pregnant). It compares them with pregnancies exposed to similar biologic medicines, to better understand risks and what to expect.
Morrisville, North CarolinaAges Any age - NCT04868526Recruiting
Food plan study for people who work nights
This study tests whether a specific dietary intervention can reduce health downsides from working night shifts. It is looking for generally healthy young adults who are able to follow the study plan and have not had certain mental health, substance use, or smoking history.
Boston, MassachusettsAges 18–45 - NCT04872660RecruitingPhase 4
Gushen Antai pill to improve IVF ongoing pregnancy rates
This trial studies whether a traditional Chinese medicine pill (Gushen Antai) can improve the chance of an IVF pregnancy that continues (“ongoing pregnancy rate”) and assess its safety. It’s for people starting their first IVF/ICSI cycle with normal ovarian function reserve.
Jinan, ShandongAges 21–42 - NCT04873050RecruitingPhase 4
Medication and lifestyle plan to bring blood sugar to normal
This Phase 4 study looks at how to help women with a recent history of gestational diabetes get their blood sugar back toward normal levels. It likely includes blood-sugar testing and a controlled diet period to see what works best.
Baton Rouge, LouisianaAges 18–45 - NCT04878094RecruitingPhase 3
Test dye imaging during surgery for ovarian cancer
This study tests whether using a special imaging dye during surgery can help surgeons better manage parts of the bowel during operations for ovarian cancer. It may help guide whether a low anterior rectosigmoid resection and reconnection (anastomosis) are needed.
Basking Ridge, New JerseyAges Any age - NCT04899908RecruitingPhase 2
Brain radiation with or without gadolinium nanoparticles for brain metastases
This trial tests whether adding tiny gadolinium-containing nanoparticles to standard brain radiation can better control brain metastases from certain cancers. It is for people with tumors that have grown after immunotherapy, are from certain cancers (like melanoma, GI, or HER2+ breast), are cystic, are large, or have come back after prior radiation.
Boston, MassachusettsAges 18 years+ - NCT04913064Recruiting
White button mushroom supplement for inflammation in high-risk breast cancer
This trial tests whether a white button mushroom powder supplement can lower inflammation in postmenopausal women who have a high risk of breast cancer. If it helps, it could improve early prevention strategies for people at higher risk.
Duarte, CaliforniaAges 21 years+ - NCT07697872Recruiting
The Dirty Nappy Study for babies with liver problems
This study looks at babies with possible liver problems (cholestasis) who have been referred to the Birmingham Liver Unit. Researchers want to collect information from nappy (diaper) samples to better understand these conditions.
BirminghamAges Up to 11 years
Hear when a new Women trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for women?
- Yes. Clin2 currently lists 1,350 recruiting women studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a women trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a women trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.